D-1144-2023 Class III Terminated
FDA drug recall D-1144-2023 was initiated by Caplin Steriles Limited on Aug 14, 2023 and is designated Class III. Reason for recall: Failed Impurities/Degradation Specifications The recall status is terminated (terminated Sep 9, 2025). Affected quantity: 19, 820 vials.
Recall details
- Product Type
- Drugs
- Report Date
- Sep 13, 2023
- Initiation Date
- Aug 14, 2023
- Termination Date
- Sep 9, 2025
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 19, 820 vials
Product description
Milrinone Lactate Injection, USP 20mg/20 mL (1mg/mL), packaged in 10 x 20 mL vials per carton, NDC 72485-502-01 (single vial), Rx only, Distributed by: Armas Pharmaceuticals, Inc. Freehold, NJ 07728(USA) Manufactured by: Caplin Steriles Limited, India, NDC 72485-502-10
Reason for recall
Failed Impurities/Degradation Specifications
Distribution pattern
Nationwide in Tennessee
Code information
Lot #: 90000228
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-1144-2023
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026